NPS Pharmaceuticals receives orphan drug designation for Natpara in Europe (BioSpace, 3 January 2014)

07 Jan 2014


NPS Pharmaceuticals reports that the European Commission has granted orphan drug designation to its recombinant human parathyroid hormone Natpara.

Full article


Share this story